{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T10:56:22Z","timestamp":1786704982043,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PON_INBIOMED ID: ARS01_01081"],"award-info":[{"award-number":["PON_INBIOMED ID: ARS01_01081"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PON_INBIOMED ID: ARS01_01081"],"award-info":[{"award-number":["PON_INBIOMED ID: ARS01_01081"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PON_INBIOMED ID: ARS01_01081"],"award-info":[{"award-number":["PON_INBIOMED ID: ARS01_01081"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PON_INBIOMED ID: ARS01_01081"],"award-info":[{"award-number":["PON_INBIOMED ID: ARS01_01081"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PON_INBIOMED ID: ARS01_01081"],"award-info":[{"award-number":["PON_INBIOMED ID: ARS01_01081"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PON_INBIOMED ID: ARS01_01081"],"award-info":[{"award-number":["PON_INBIOMED ID: ARS01_01081"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neurodegenerative diseases represent a major healthcare challenge for aging populations, characterized by the progressive decline of neuronal function and subsequent brain atrophy. Despite differences in the brain regions affected and the underlying causes, these pathologies share common cellular and molecular mechanisms, including oxidative stress and mitochondrial dysfunction.\u00a0Among neurodegenerative disorders, Parkinson\u2019s disease (PD) is particularly associated with oxidative stress\u2013driven dopaminergic neurodegeneration, in which reactive oxygen species (ROS) play a crucial role by contributing to cellular damage and neuronal death. This study investigates the role of Up-Regulated Gene 7 (URG7), a protein localized in the endoplasmic reticulum, in modulating oxidative stress in genetically engineered SH-SY5Y neuroblastoma cells overexpressing URG7,\u00a0exposed to 6-hydroxydopamine (6-OHDA), a neurotoxin used as a Parkinson\u2019s disease mimetic. We hypothesized that URG7 overexpression mechanistically modulates oxidative stress responses and mitochondrial integrity in neuronal cells subjected to Parkinson\u2019s disease\u2013related oxidative insult. Our results demonstrate that URG7 significantly reduces cell death and oxidative stress by enhancing cellular antioxidant defenses. Specifically, URG7 upregulates key antioxidant enzymes, including catalase and superoxide dismutase 2, and activates the Nrf2 signaling pathway, crucial for cellular detoxification. Furthermore, URG7 preserves mitochondrial membrane potential and regulates the expression of proteins involved in mitochondrial quality control, such as PINK1, Parkin, and DJ-1. Overall, these findings suggest that URG7 acts as a protective sentinel against oxidative stress and mitochondrial dysfunction, highlighting its potential as a therapeutic target for neurodegenerative diseases, particularly Parkinson\u2019s disease. Further investigation into the molecular mechanisms of URG7, building on the biological evidence provided here, could pave the way for new neuroprotective strategies aimed at counteracting oxidative damage and promoting neuronal survival.<\/jats:p>","DOI":"10.1038\/s41598-026-38925-6","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:54:54Z","timestamp":1771520094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting oxidative stress and mitochondrial dysfunction via URG7 overexpression in an in vitro Parkinson\u2019s disease neuronal model"],"prefix":"10.1038","volume":"16","author":[{"given":"Ilaria","family":"Nigro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocchina","family":"Miglionico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Lela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Milella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faustino","family":"Bisaccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Armentano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"38925_CR1","doi-asserted-by":"publisher","first-page":"952161","DOI":"10.3389\/fpubh.2022.952161","volume":"10","author":"C Ding","year":"2022","unstructured":"Ding, C. et al. Regional, and National burden and attributable risk factors of neurological disorders: the global burden of disease study 1990\u20132019. Front. public. Heal. 10, 952161. https:\/\/doi.org\/10.3389\/fpubh.2022.952161 (2022).","journal-title":"Front. public. Heal"},{"key":"38925_CR2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong, M. J. & Okun, M. S. Diagnosis and treatment of Parkinson disease: A review. JAMA 323, 548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360 (2020).","journal-title":"JAMA"},{"key":"38925_CR3","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"F Chen","year":"2021","unstructured":"Chen, F., Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet (London England). 397, 2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X (2021).","journal-title":"Lancet (London England)"},{"key":"38925_CR4","doi-asserted-by":"publisher","unstructured":"Liu, Z., Zhou, T., Ziegler, A. C., Dimitrion, P. & Zuo, L. Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. https:\/\/doi.org\/10.1155\/2017\/2525967 (2017).","DOI":"10.1155\/2017\/2525967"},{"key":"38925_CR5","doi-asserted-by":"publisher","first-page":"S399","DOI":"10.3233\/JAD-220682","volume":"94","author":"P Naren","year":"2023","unstructured":"Naren, P. et al. Pathological and therapeutic advances in parkinson\u2019s disease: mitochondria in the interplay. J. Alzheimers Dis. 94, S399\u2013S428. https:\/\/doi.org\/10.3233\/JAD-220682 (2023).","journal-title":"J. Alzheimers Dis."},{"key":"38925_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12035-025-05389-0","volume":"63","author":"R Jain","year":"2025","unstructured":"Jain, R., Vora, L., Nathiya, D. & Khatri, D. K. Nrf2-Keap1 pathway and NLRP3 inflammasome in parkinson\u2019s disease: mechanistic crosstalk and therapeutic implications. Mol. Neurobiol. 63, 91. https:\/\/doi.org\/10.1007\/s12035-025-05389-0 (2025).","journal-title":"Mol. Neurobiol."},{"key":"38925_CR7","doi-asserted-by":"publisher","first-page":"101915","DOI":"10.1016\/j.arr.2023.101915","volume":"87","author":"S Rajan","year":"2023","unstructured":"Rajan, S. et al. Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in parkinson\u2019s disease. Ageing Res. Rev. 87, 101915. https:\/\/doi.org\/10.1016\/j.arr.2023.101915 (2023).","journal-title":"Ageing Res. Rev."},{"key":"38925_CR8","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.2c00819","author":"KP Tryphena","year":"2023","unstructured":"Tryphena, K. P. et al. Mitochondrial complex I as a pathologic and therapeutic target for parkinson\u2019s disease. ACS Chem. Neurosci. https:\/\/doi.org\/10.1021\/acschemneuro.2c00819 (2023).","journal-title":"ACS Chem. Neurosci."},{"key":"38925_CR9","doi-asserted-by":"publisher","first-page":"e00292","DOI":"10.1016\/j.neurot.2023.10.002","volume":"21","author":"MM Klemmensen","year":"2024","unstructured":"Klemmensen, M. M., Borrowman, S. H., Pearce, C., Pyles, B. & Chandra, B. Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics 21, e00292. https:\/\/doi.org\/10.1016\/j.neurot.2023.10.002 (2024).","journal-title":"Neurotherapeutics"},{"key":"38925_CR10","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s11064-023-03904-0","volume":"48","author":"S Moradi Vastegani","year":"2023","unstructured":"Moradi Vastegani, S. et al. Mitochondrial dysfunction and parkinson\u2019s disease: pathogenesis and therapeutic strategies. Neurochem Res. 48, 2285\u20132308. https:\/\/doi.org\/10.1007\/s11064-023-03904-0 (2023).","journal-title":"Neurochem Res."},{"key":"38925_CR11","doi-asserted-by":"publisher","first-page":"175300","DOI":"10.1016\/j.ejphar.2022.175300","volume":"934","author":"M Khot","year":"2022","unstructured":"Khot, M. et al. NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in parkinson\u2019s disease. Eur. J. Pharmacol. 934, 175300. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175300 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"38925_CR12","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41556-024-01513-9","volume":"26","author":"DP Narendra","year":"2024","unstructured":"Narendra, D. P. & Youle, R. J. The role of PINK1-Parkin in mitochondrial quality control. Nat. Cell. Biol. 26, 1639\u20131651. https:\/\/doi.org\/10.1038\/s41556-024-01513-9 (2024).","journal-title":"Nat. Cell. Biol."},{"key":"38925_CR13","doi-asserted-by":"publisher","unstructured":"Panicker, N., Ge, P., Dawson, V. L. & Dawson, T. M. The cell biology of parkinson\u2019s disease. J. Cell. Biol. 220. https:\/\/doi.org\/10.1083\/jcb.202012095 (2021).","DOI":"10.1083\/jcb.202012095"},{"key":"38925_CR14","doi-asserted-by":"publisher","unstructured":"Barazzuol, L., Giamogante, F., Brini, M. & Cal\u00ec, T. PINK1\/parkin mediated mitophagy, Ca(2+) signalling, and ER-mitochondria contacts in Parkinson\u2019s disease. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21051772 (2020).","DOI":"10.3390\/ijms21051772"},{"key":"38925_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.7861\/clinmed.2020-0220","volume":"20","author":"C Kobylecki","year":"2020","unstructured":"Kobylecki, C. Update on the diagnosis and management of parkinson\u2019s disease. Clin. Med. 20, 393\u2013398. https:\/\/doi.org\/10.7861\/clinmed.2020-0220 (2020).","journal-title":"Clin. Med."},{"key":"38925_CR16","doi-asserted-by":"publisher","first-page":"996","DOI":"10.2174\/0118715273258646230920074421","volume":"23","author":"P Chhabra","year":"2024","unstructured":"Chhabra, P. et al. Pre-Clinical aspects and contemporary treatments of parkinson\u2019s disease. CNS Neurol. Disord Drug Targets. 23, 996\u20131014. https:\/\/doi.org\/10.2174\/0118715273258646230920074421 (2024).","journal-title":"CNS Neurol. Disord Drug Targets"},{"key":"38925_CR17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/neurolint16030037","volume":"16","author":"E Bej","year":"2024","unstructured":"Bej, E., Cesare, P., Volpe, A. R., d\u2019Angelo, M. & Castelli, V. Oxidative stress and neurodegeneration: insights and therapeutic strategies for parkinson\u2019s disease. Neurol. Int. 16, 502\u2013517. https:\/\/doi.org\/10.3390\/neurolint16030037 (2024).","journal-title":"Neurol. Int."},{"key":"38925_CR18","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1016\/j.febslet.2013.07.042","volume":"587","author":"A Ostuni","year":"2013","unstructured":"Ostuni, A. et al. The hepatitis B x antigen Anti-Apoptotic effector URG7 is localized to the Endoplasmic reticulum membrane. FEBS Lett. 587, 3058\u20133062. https:\/\/doi.org\/10.1016\/j.febslet.2013.07.042 (2013).","journal-title":"FEBS Lett."},{"key":"38925_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/boc.201800004","volume":"110","author":"MF Armentano","year":"2018","unstructured":"Armentano, M. F. et al. New insights on the functional role of URG7 in the cellular response to ER stress. Biol. Cell. 110, 147\u2013158. https:\/\/doi.org\/10.1111\/boc.201800004 (2018).","journal-title":"Biol. Cell."},{"key":"38925_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/ijms25010481","volume":"25","author":"I Nigro","year":"2023","unstructured":"Nigro, I. et al. Neuroprotective effect of antiapoptotic URG7 protein on human neuroblastoma cell line SH-SY5Y. Int. J. Mol. Sci. 25, 481. https:\/\/doi.org\/10.3390\/ijms25010481 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"38925_CR21","first-page":"297","volume":"46","author":"K Jellinger","year":"1995","unstructured":"Jellinger, K., Linert, L., Kienzl, E., Herlinger, E. & Youdim, M. B. Chemical evidence for 6-Hydroxydopamine to be an endogenous toxic factor in the pathogenesis of parkinson\u2019s disease. J. Neural Transm Suppl. 46, 297\u2013314 (1995).","journal-title":"J. Neural Transm Suppl."},{"key":"38925_CR22","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/BF00978370","volume":"18","author":"R Andrew","year":"1993","unstructured":"Andrew, R. et al. The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem Res. 18, 1175\u20131177. https:\/\/doi.org\/10.1007\/BF00978370 (1993).","journal-title":"Neurochem Res."},{"key":"38925_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-3-7091-6842-4_7","volume":"50","author":"Y Glinka","year":"1997","unstructured":"Glinka, Y., Gassen, M. & Youdim, M. B. H. Mechanism of 6-Hydroxydopamine neurotoxicity. J. Neural Transm Suppl. 50, 55\u201366. https:\/\/doi.org\/10.1007\/978-3-7091-6842-4_7 (1997).","journal-title":"J. Neural Transm Suppl."},{"key":"38925_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF03033565","volume":"11","author":"N Simola","year":"2007","unstructured":"Simola, N., Morelli, M. & Carta, A. R. The 6-Hydroxydopamine model of parkinson\u2019s disease. Neurotox. Res. 11, 151\u2013167. https:\/\/doi.org\/10.1007\/BF03033565 (2007).","journal-title":"Neurotox. Res."},{"key":"38925_CR25","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/j.1742-4658.2012.08491.x","volume":"279","author":"F Blandini","year":"2012","unstructured":"Blandini, F. & Armentero, M. T. Animal models of parkinson\u2019s disease. FEBS J. 279, 1156\u20131166. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08491.x (2012).","journal-title":"FEBS J."},{"key":"38925_CR26","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.nrl.2015.06.011","volume":"32","author":"D Hernandez-Baltazar","year":"2017","unstructured":"Hernandez-Baltazar, D., Zavala-Flores, L. M. & Villanueva-Olivo, A. El Modelo de 6-Hidroxidopamina y La Fisiopatolog\u00eda parkinsoniana: Nuevos Hallazgos En Un Viejo Modelo. Neurologia 32, 533\u2013539. https:\/\/doi.org\/10.1016\/j.nrl.2015.06.011 (2017).","journal-title":"Neurologia"},{"key":"38925_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell, A. M. & Youle, R. J. The roles of PINK1, Parkin, and mitochondrial fidelity in parkinson\u2019s disease. Neuron 85, 257\u2013273. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.007 (2015).","journal-title":"Neuron"},{"key":"38925_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0896-6273(03)00201-0","volume":"38","author":"MB Feany","year":"2003","unstructured":"Feany, M. B., Pallanck, L. J. & Parkin Multipurp. Neuroprotective Agent? Neuron 38, 13\u201316, doi:https:\/\/doi.org\/10.1016\/S0896-6273(03)00201-0. (2003).","journal-title":"Multipurp. Neuroprotective Agent? Neuron"},{"key":"38925_CR29","doi-asserted-by":"publisher","first-page":"9103","DOI":"10.1073\/pnas.0402959101","volume":"101","author":"RM Canet-Avil\u00e9s","year":"2004","unstructured":"Canet-Avil\u00e9s, R. M. et al. The parkinson\u2019s disease DJ-1 is neuroprotective due to Cysteine-Sulfinic Acid-Driven mitochondrial localization. Proc. Natl. Acad. Sci. U S A. 101, 9103\u20139108. https:\/\/doi.org\/10.1073\/pnas.0402959101 (2004).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"38925_CR30","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.bbadis.2006.03.008","volume":"1762","author":"SC Barber","year":"2006","unstructured":"Barber, S. C., Mead, R. J. & Shaw, P. J. Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target. Biochim. Biophys. Acta - Mol. Basis Dis. 1762, 1051\u20131067. https:\/\/doi.org\/10.1016\/j.bbadis.2006.03.008 (2006).","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"38925_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.biopha.2003.11.004","volume":"58","author":"J Emerit","year":"2004","unstructured":"Emerit, J., Edeas, M. & Bricaire, F. Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother. 58, 39\u201346. https:\/\/doi.org\/10.1016\/j.biopha.2003.11.004 (2004).","journal-title":"Biomed. Pharmacother"},{"key":"38925_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00415-004-0348-9","volume":"251","author":"Y Gilgun-Sherki","year":"2004","unstructured":"Gilgun-Sherki, Y., Melamed, E. & Offen, D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J. Neurol. 251, 261\u2013268. https:\/\/doi.org\/10.1007\/s00415-004-0348-9 (2004).","journal-title":"J. Neurol."},{"key":"38925_CR33","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1007\/s11064-012-0838-6","volume":"37","author":"J Iglesias-Gonz\u00e1lez","year":"2012","unstructured":"Iglesias-Gonz\u00e1lez, J. et al. Differential toxicity of 6-Hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase. Neurochem Res. 37, 2150\u20132160. https:\/\/doi.org\/10.1007\/s11064-012-0838-6 (2012).","journal-title":"Neurochem Res."},{"key":"38925_CR34","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.4103\/1673-5374.300980","volume":"16","author":"J Dorszewska","year":"2021","unstructured":"Dorszewska, J. et al. Oxidative stress factors in parkinson\u2019s disease. Neural Regen Res. 16, 1383\u20131391. https:\/\/doi.org\/10.4103\/1673-5374.300980 (2021).","journal-title":"Neural Regen Res."},{"key":"38925_CR35","doi-asserted-by":"crossref","unstructured":"In, I., Aerobic, T. H. E., Of, A. & Conditions, R. 6-hydroxydopamine: relative importance under different. 6, 271\u2013284. (1989).","DOI":"10.1016\/0891-5849(89)90054-3"},{"key":"38925_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2005.12.009","volume":"160","author":"M Valko","year":"2006","unstructured":"Valko, M. et al. Metals and antioxidants in oxidative Stress-Induced cancer. Chem. Biol. Interact. 160, 1\u201340. https:\/\/doi.org\/10.1016\/j.cbi.2005.12.009 (2006).","journal-title":"Chem. Biol. Interact."},{"key":"38925_CR37","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1046\/j.1471-4159.2000.0741605.x","volume":"74","author":"R Soto-Otero","year":"2000","unstructured":"Soto-Otero, R., M\u00e9ndez-\u00c1lvarez, E., Hermida-Ameijeiras, \u00c1., Mu\u00f1oz-Pati\u00f1o, A. M. & Labandeira-Garcia, J. L. Autoxidation and neurotoxicity of 6-Hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of parkinson\u2019s disease. J. Neurochem. 74, 1605\u20131612. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0741605.x (2000).","journal-title":"J. Neurochem"},{"key":"38925_CR38","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S0891-5849(01)00679-7","volume":"31","author":"E M\u00e9ndez-\u00c1lvarez","year":"2001","unstructured":"M\u00e9ndez-\u00c1lvarez, E., Soto-Otero, R., Hermida-Ameijeiras, \u00c1., L\u00f3pez-Mart\u00edn, M. E. & Labandeira-Garc\u00eda, J. L. Effect of iron and manganese on hydroxyl radical production by 6-Hydroxydopamine: mediation of antioxidants. Free Radic Biol. Med. 31, 986\u2013998. https:\/\/doi.org\/10.1016\/S0891-5849(01)00679-7 (2001).","journal-title":"Free Radic Biol. Med."},{"key":"38925_CR39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","volume":"65","author":"D Blum","year":"2001","unstructured":"Blum, D. et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in parkinson\u2019s disease. Prog Neurobiol. 65, 135\u2013172. https:\/\/doi.org\/10.1016\/S0301-0082(01)00003-X (2001).","journal-title":"Prog Neurobiol."},{"key":"38925_CR40","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/B978-0-12-815950-7.00040-0","volume":"2","author":"K Kaczy\u0144ska","year":"2020","unstructured":"Kaczy\u0144ska, K. & Andrzejewski, K. 6-Hydroxydopamine-Induced model of parkinson\u2019s disease. Genet. Neurol. Behav. Diet. Park Dis. Neurosci. Park Dis. Vol. 2, 627\u2013642. https:\/\/doi.org\/10.1016\/B978-0-12-815950-7.00040-0 (2020).","journal-title":"Genet. Neurol. Behav. Diet. Park Dis. Neurosci. Park Dis. Vol"},{"key":"38925_CR41","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1016\/s0021-9258(19)42751-8","volume":"249","author":"G Cohen","year":"1974","unstructured":"Cohen, G. & Heikkila, R. E. The generation of hydrogen Peroxide, superoxide radical, and hydroxyl radical by 6 Hydroxydopamine, dialuric Acid, and related cytotoxic agents. J. Biol. Chem. 249, 2447\u20132452. https:\/\/doi.org\/10.1016\/s0021-9258(19)42751-8 (1974).","journal-title":"J. Biol. Chem."},{"key":"38925_CR42","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.freeradbiomed.2007.04.028","volume":"43","author":"SM Kulich","year":"2007","unstructured":"Kulich, S. M., Horbinski, C., Patel, M. & Chu, C. T. 6-Hydroxydopamine induces mitochondrial ERK activation. Free Radic Biol. Med. 43, 372\u2013383. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2007.04.028 (2007).","journal-title":"Free Radic Biol. Med."},{"key":"38925_CR43","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0306-4522(97)00665-9","volume":"85","author":"M Asanuma","year":"1998","unstructured":"Asanuma, M., Hirata, H. & Cadet, J. L. Attenuation of 6-Hydroxydopamine-Induced dopaminergic nigrostriatal lesions in superoxide dismutase Transgenic mice. Neuroscience 85, 907\u2013917. https:\/\/doi.org\/10.1016\/S0306-4522(97)00665-9 (1998).","journal-title":"Neuroscience"},{"key":"38925_CR44","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1023\/A:1021152115752","volume":"24","author":"H Kabuto","year":"1999","unstructured":"Kabuto, H., Yokoi, I., Iwata-Ichikawa, E. & Ogawa, N. EPC-K1, a hydroxyl radical Scavenger, prevents 6-Hydroxydopamine-Induced dopamine depletion in the mouse striatum by up-Regulation of catalase activity. Neurochem Res. 24, 1543\u20131548. https:\/\/doi.org\/10.1023\/A:1021152115752 (1999).","journal-title":"Neurochem Res."},{"key":"38925_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.1471-4159.2002.00952.x","volume":"82","author":"M Barkats","year":"2002","unstructured":"Barkats, M., Millecamps, S., Bilang-Bleuel, A. & Mallet, J. Neuronal transfer of the human Cu\/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-Hydroxydopamine. J. Neurochem. 82, 101\u2013109. https:\/\/doi.org\/10.1046\/j.1471-4159.2002.00952.x (2002).","journal-title":"J. Neurochem"},{"key":"38925_CR46","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1042\/bj3110821","volume":"311","author":"S Fu","year":"1995","unstructured":"Fu, S., Gebicki, S., Jessup, W., Gebicki, J. M. & Dean, R. T. Biological fate of amino Acid, peptide and protein hydroperoxides. Biochem. J. 311, 821\u2013827. https:\/\/doi.org\/10.1042\/bj3110821 (1995).","journal-title":"Biochem. J."},{"key":"38925_CR47","doi-asserted-by":"publisher","first-page":"15091","DOI":"10.1016\/s0021-9258(18)98591-1","volume":"266","author":"J Aikens","year":"1991","unstructured":"Aikens, J. & Dix, T. A. Perhydroxyl radical (HOO\u2022) initiated lipid peroxidation: the role of fatty acid hydroperoxides. J. Biol. Chem. 266, 15091\u201315098. https:\/\/doi.org\/10.1016\/s0021-9258(18)98591-1 (1991).","journal-title":"J. Biol. Chem."},{"key":"38925_CR48","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1042\/bj2890743","volume":"289","author":"S Gebicki","year":"1993","unstructured":"Gebicki, S. & Gebicki, J. M. Formation of peroxides in amino acids and proteins exposed to oxygen free radicals. Biochem. J. 289, 743\u2013749. https:\/\/doi.org\/10.1042\/bj2890743 (1993).","journal-title":"Biochem. J."},{"key":"38925_CR49","first-page":"5196","volume":"62","author":"RK Thimmulappa","year":"2002","unstructured":"Thimmulappa, R. K. et al. Identification of Nrf2-Regulated genes induced by the chemopreventive agent Sulforaphane by oligonucleotide microarray. Cancer Res. 62, 5196\u20135203 (2002).","journal-title":"Cancer Res."},{"key":"38925_CR50","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pharmthera.2015.11.003","volume":"157","author":"I Buendia","year":"2016","unstructured":"Buendia, I. et al. Nrf2-ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol. Ther. 157, 84\u2013104. https:\/\/doi.org\/10.1016\/j.pharmthera.2015.11.003 (2016).","journal-title":"Pharmacol. Ther."},{"key":"38925_CR51","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1128\/mcb.24.16.7130-7139.2004","volume":"24","author":"A Kobayashi","year":"2004","unstructured":"Kobayashi, A. et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-Based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24, 7130\u20137139. https:\/\/doi.org\/10.1128\/mcb.24.16.7130-7139.2004 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"38925_CR52","doi-asserted-by":"crossref","unstructured":"Dhakshinamoorthy, S. & Jaiswal, A. K. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD (P) H: Quinone Oxidoreductase1 Gene. 3906\u20133917. (2001).","DOI":"10.1038\/sj.onc.1204506"},{"key":"38925_CR53","doi-asserted-by":"publisher","unstructured":"Rushmore, T. H., King, R. G., Paulson, K. E. & Pickett, C. B. Regulation of glutathione S-Transferase Ya subunit gene expression: identification of a unique Xenobiotic-Responsive element controlling inducible expression by planar aromatic compounds. Proc. Natl. Acad. Sci. U S A. 87, 3826\u20133830. https:\/\/doi.org\/10.1073\/pnas.87.10.3826 (1990).","DOI":"10.1073\/pnas.87.10.3826"},{"key":"38925_CR54","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1515\/BC.2006.164","volume":"387","author":"KI Tong","year":"2006","unstructured":"Tong, K. I., Kobayashi, A., Katsuoka, F. & Yamamoto, M. Two-Site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism. Biol. Chem. 387, 1311\u20131320. https:\/\/doi.org\/10.1515\/BC.2006.164 (2006).","journal-title":"Biol. Chem."},{"key":"38925_CR55","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.brainres.2007.01.131","volume":"1144","author":"RJ Jakel","year":"2007","unstructured":"Jakel, R. J., Townsend, J. A., Kraft, A. D. & Johnson, J. A. Nrf2-Mediated protection against 6-Hydroxydopamine. Brain Res. 1144, 192\u2013201. https:\/\/doi.org\/10.1016\/j.brainres.2007.01.131 (2007).","journal-title":"Brain Res."},{"key":"38925_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2022.919233","volume":"13","author":"XX Yang","year":"2022","unstructured":"Yang, X. X., Yang, R. & Zhang, F. Role of Nrf2 in parkinson\u2019s disease: toward new perspectives. Front. Pharmacol. 13, 1\u201312. https:\/\/doi.org\/10.3389\/fphar.2022.919233 (2022).","journal-title":"Front. Pharmacol."},{"key":"38925_CR57","doi-asserted-by":"publisher","first-page":"103413","DOI":"10.1016\/j.mcn.2019.103413","volume":"101","author":"N Ammal Kaidery","year":"2019","unstructured":"Ammal Kaidery, N., Ahuja, M. & Thomas, B. Crosstalk between Nrf2 signaling and mitochondrial function in parkinson\u2019s disease. Mol. Cell. Neurosci. 101, 103413. https:\/\/doi.org\/10.1016\/j.mcn.2019.103413 (2019).","journal-title":"Mol. Cell. Neurosci."},{"key":"38925_CR58","doi-asserted-by":"publisher","unstructured":"Villavicencio Tejo, F. & Quintanilla, R. A. Contribution of the Nrf2 pathway on oxidative damage and mitochondrial failure in Parkinson and alzheimer\u2019s disease. Antioxidants 10 https:\/\/doi.org\/10.3390\/antiox10071069 (2021).","DOI":"10.3390\/antiox10071069"},{"key":"38925_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox10111649","volume":"10","author":"JA Parga","year":"2021","unstructured":"Parga, J. A., Rodriguez-Perez, A. I., Garcia-Garrote, M., Rodriguez-Pallares, J. & Labandeira-Garcia, J. L. Nrf2 activation and downstream effects: focus on parkinson\u2019s disease and brain angiotensin. Antioxidants 10, 1\u201323. https:\/\/doi.org\/10.3390\/antiox10111649 (2021).","journal-title":"Antioxidants"},{"key":"38925_CR60","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrn1868","volume":"7","author":"PM Abou-Sleiman","year":"2006","unstructured":"Abou-Sleiman, P. M., Muqit, M. M. K. & Wood, N. W. Expanding insights of mitochondrial dysfunction in parkinson\u2019s disease. Nat. Rev. Neurosci. 7, 207\u2013219. https:\/\/doi.org\/10.1038\/nrn1868 (2006).","journal-title":"Nat. Rev. Neurosci."},{"key":"38925_CR61","doi-asserted-by":"publisher","unstructured":"Greenamyre, J. T. & Hastings, T. G. Parkinsons-divergent-causes-convergent-mechanisms. Biomedicine. https:\/\/doi.org\/10.1126\/science.1098966.","DOI":"10.1126\/science.1098966"},{"key":"38925_CR62","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.conb.2007.04.010","volume":"17","author":"MW Dodson","year":"2007","unstructured":"Dodson, M. W. & Guo, M. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in parkinson\u2019s disease. Curr. Opin. Neurobiol. 17, 331\u2013337. https:\/\/doi.org\/10.1016\/j.conb.2007.04.010 (2007).","journal-title":"Curr. Opin. Neurobiol."},{"key":"38925_CR63","doi-asserted-by":"publisher","unstructured":"Narendra, D. P. et al. PINK1 is selectively stabilized on impaired mitochondria to activate parkin. PLoS Biol. 8. https:\/\/doi.org\/10.1371\/journal.pbio.1000298 (2010).","DOI":"10.1371\/journal.pbio.1000298"},{"key":"38925_CR64","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1083\/jcb.200910140","volume":"189","author":"N Matsuda","year":"2010","unstructured":"Matsuda, N. et al. PINK1 stabilized by mitochondrial depolarization recruits parkin to damaged mitochondria and activates latent parkin for mitophagy. J. Cell. Biol. 189, 211\u2013221. https:\/\/doi.org\/10.1083\/jcb.200910140 (2010).","journal-title":"J. Cell. Biol."},{"key":"38925_CR65","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11910-011-0187-x","volume":"11","author":"JH Pogson","year":"2011","unstructured":"Pogson, J. H., Ivatt, R. M. & Whitworth, A. J. Molecular mechanisms of PINK1-Related neurodegeneration. Curr. Neurol. Neurosci. Rep. 11, 283\u2013290. https:\/\/doi.org\/10.1007\/s11910-011-0187-x (2011).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"38925_CR66","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/hmg\/ddg044","volume":"12","author":"F Darios","year":"2003","unstructured":"Darios, F. et al. Parkin prevents mitochondrial swelling and cytochrome c release in Mitochondria-Dependent cell death. Hum. Mol. Genet. 12, 517\u2013526. https:\/\/doi.org\/10.1093\/hmg\/ddg044 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"38925_CR67","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/mds.10695","volume":"19","author":"M M\u00fcft\u00fcoglu","year":"2004","unstructured":"M\u00fcft\u00fcoglu, M. et al. Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov. Disord. 19, 544\u2013548. https:\/\/doi.org\/10.1002\/mds.10695 (2004).","journal-title":"Mov. Disord"},{"key":"38925_CR68","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.tins.2014.03.004","volume":"37","author":"LA Scarffe","year":"2014","unstructured":"Scarffe, L. A., Stevens, D. A., Dawson, V. L. & Dawson, T. M. Parkin and PINK1: much more than mitophagy. Trends Neurosci. 37, 315\u2013324. https:\/\/doi.org\/10.1016\/j.tins.2014.03.004 (2014).","journal-title":"Trends Neurosci."},{"key":"38925_CR69","unstructured":"Sciences, M. PINK1\/Parkin mediated mitophagy, Ca2+\u2009signalling, and ER \u2013 Mitochondria Contacts in Parkinson\u2019s disease. (2020)."},{"key":"38925_CR70","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1080\/15548627.2016.1277309","volume":"13","author":"V Gelmetti","year":"2017","unstructured":"Gelmetti, V. et al. PINK1 and BECN1 Relocalize at Mitochondria-Associated membranes during mitophagy and promote ER-Mitochondria tethering and autophagosome formation. Autophagy 13, 654\u2013669. https:\/\/doi.org\/10.1080\/15548627.2016.1277309 (2017).","journal-title":"Autophagy"},{"key":"38925_CR71","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.nbd.2009.08.011","volume":"36","author":"R Kumaran","year":"2009","unstructured":"Kumaran, R. et al. Differential DJ-1 gene expression in parkinson\u2019s disease. Neurobiol. Dis. 36, 393\u2013400. https:\/\/doi.org\/10.1016\/j.nbd.2009.08.011 (2009).","journal-title":"Neurobiol. Dis."},{"key":"38925_CR72","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1093\/hmg\/ddi211","volume":"14","author":"L Zhang","year":"2005","unstructured":"Zhang, L. et al. Mitochondrial localization of the parkinson\u2019s disease related protein DJ-1: implications for pathogenesis. Hum. Mol. Genet. 14, 2063\u20132073. https:\/\/doi.org\/10.1093\/hmg\/ddi211 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"38925_CR73","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"V Bonifati","year":"2003","unstructured":"Bonifati, V. et al. Mutations in the DJ-1 gene associated with autosomal recessive Early-Onset parkinsonism. Sci. (80-). 299, 256\u2013259. https:\/\/doi.org\/10.1126\/science.1077209 (2003).","journal-title":"Sci. (80-)"},{"key":"38925_CR74","doi-asserted-by":"publisher","first-page":"14807","DOI":"10.1073\/pnas.0703219104","volume":"104","author":"E Andres-Mateos","year":"2007","unstructured":"Andres-Mateos, E. et al. DJ-1 gene deletion reveals that DJ-1 is an atypical Peroxiredoxin-like peroxidase. Proc. Natl. Acad. Sci. U S A. 104, 14807\u201314812. https:\/\/doi.org\/10.1073\/pnas.0703219104 (2007).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"38925_CR75","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.bbrc.2009.10.025","volume":"390","author":"T Hayashi","year":"2009","unstructured":"Hayashi, T. et al. M. DJ-1 binds to mitochondrial complex I and maintains its activity. Biochem. Biophys. Res. Commun. 390, 667\u2013672. https:\/\/doi.org\/10.1016\/j.bbrc.2009.10.025 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"38925_CR76","doi-asserted-by":"publisher","unstructured":"Krebiehl, G. et al. Reduced basal autophagy and impaired mitochondrial dynamics due to loss of parkinson\u2019s Disease-Associated protein DJ-1. PLoS One. 5 https:\/\/doi.org\/10.1371\/journal.pone.0009367 (2010).","DOI":"10.1371\/journal.pone.0009367"},{"key":"38925_CR77","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/10715760100300831","volume":"35","author":"A Mitsumoto","year":"2001","unstructured":"Mitsumoto, A. et al. Oxidized forms of Peroxiredoxins and DJ-1 on Two-Dimensional gels increased in response to sublethal levels of Paraquat. Free Radic Res. 35, 301\u2013310. https:\/\/doi.org\/10.1080\/10715760100300831 (2001).","journal-title":"Free Radic Res."},{"key":"38925_CR78","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1093\/hmg\/ddn230","volume":"17","author":"N Zhong","year":"2008","unstructured":"Zhong, N. & Xu, J. Synergistic activation of the human MnSOD promoter by DJ-1 and PGC-1\u03b1: regulation by sumoylation and oxidation. Hum. Mol. Genet. 17, 3357\u20133367. https:\/\/doi.org\/10.1093\/hmg\/ddn230 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"38925_CR79","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1073\/pnas.0812745106","volume":"106","author":"S Vasseur","year":"2009","unstructured":"Vasseur, S. et al. DJ-1\/PARK7 is an important mediator of Hypoxia-Induced cellular responses. Proc. Natl. Acad. Sci. U S A. 106, 1111\u20131116. https:\/\/doi.org\/10.1073\/pnas.0812745106 (2009).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"38925_CR80","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/hmg\/ddi134","volume":"14","author":"J Xu","year":"2005","unstructured":"Xu, J. et al. The parkinson\u2019s Disease-Associated DJ-1 protein is a transcriptional Co-Activator that protects against neuronal apoptosis. Hum. Mol. Genet. 14, 1231\u20131241. https:\/\/doi.org\/10.1093\/hmg\/ddi134 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"38925_CR81","doi-asserted-by":"crossref","unstructured":"Xicoy, H., Wieringa, B. & Martens, G. J. M. The SH-SY5Y cell line in parkinson\u2019s disease research: A systematic review. Mol. Neurodegener. (2017).","DOI":"10.1186\/s13024-017-0149-0"},{"key":"38925_CR82","doi-asserted-by":"publisher","first-page":"112227","DOI":"10.1016\/j.fct.2021.112227","volume":"152","author":"F Agahi","year":"2021","unstructured":"Agahi, F., Juan-Garc\u00eda, A., Font, G. & Juan, C. Study of enzymatic activity in human neuroblastoma cells SH-SY5Y exposed to zearalenone\u2019s derivates and Beauvericin. Food Chem. Toxicol. 152, 112227. https:\/\/doi.org\/10.1016\/j.fct.2021.112227 (2021).","journal-title":"Food Chem. Toxicol."},{"key":"38925_CR83","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MMA Bradford","year":"1976","unstructured":"Bradford, M. M. A. & Rapid Sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-Dye binding. Anal. Biochem. 72, 248\u2013254. https:\/\/doi.org\/10.1016\/0003-2697(76)90527-3 (1976).","journal-title":"Anal. Biochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38925-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38925-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38925-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:31:48Z","timestamp":1781634708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38925-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["38925"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-38925-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9955"}}